Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked US list prices on more than 250 drugs on Wednesday.
Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked US list prices on more than 250 drugs on Wednesday.